

产品介绍 评论(0)
物种
Human分子别名
CDw137, ILA, TNFRSF9Accession
Q07011表达序列
Leu24-Gln186, with C-terminal Human IgG Fc
表达宿主
HEK293分子量
50-60kDa
纯度
>95% by SDS-PAGE内毒素含量
<0.1EU/μg标记
Unconjugated标签
Human Fc Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
文献引用
1. Melero I, et al. (2008) Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends Pharmacol Sci. 29(8): 383-90. 2. Thum E, et al. (2009) CD137, implications in immunity and potential for therapy. Front Biosci. 14: 4173-88.
CD137 (also known as 4-1BB) is a surface co-stimulatory glycoprotein originally described as present on activated T lymphocytes, which belongs to the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 and CD137L are expressed in different human primary tumor tissues, suggesting that they may influence the progression of tumors. The best characterized activity of CD137 is its costimulatory activity for activated T cells.
电泳
1μg (R: reducing conditions, N: non-reducing conditions).
ELISA
Immobilized Human 4-1BB Ligand/TNFSF9 Trimer Protein at 2.0μg/mL (100μL/well) can bind 4-1BB/CD137 Fc Chimera Protein, Human (Cat. No. UA010653) with EC50 of 15.91-25.84 ng/mL.







评论(0)